نتایج جستجو برای: brca2 gene promoter

تعداد نتایج: 1174704  

2012
Tamara Hansmann Galyna Pliushch Monika Leubner Patricia Kroll Daniela Endt Andrea Gehrig Sabine Preisler-Adams Peter Wieacker Thomas Haaf

Genetic defects in breast cancer (BC) susceptibility genes, most importantly BRCA1 and BRCA2, account for ~40% of hereditary BC and ovarian cancer (OC). Little is known about the contribution of constitutive (soma-wide) epimutations to the remaining cases. We developed bisulfite pyrosequencing assays to screen >600 affected BRCA1/BRCA2 mutation-negative patients from the German Consortium for H...

Journal: :hepatitis monthly 0
sahand ghaleh baghi baqiyatallah research center for gastroenterology and liver diseases (brcgl), tehran, ir iran; department of otolaryngology and head and neck surgery, rasool akram hospital, tehran, ir iran; department of otolaryngology and head and neck surgery, rasool akram hospital, tehran, ir iran. tel: +98-9126079880 seyed moayed alavian baqiyatallah research center for gastroenterology and liver diseases (brcgl), tehran, ir iran; middle east liver disease center (meld), tehran, ir iran leila mehrnoush baqiyatallah research center for gastroenterology and liver diseases (brcgl), tehran, ir iran shima salimi baqiyatallah research center for gastroenterology and liver diseases (brcgl), tehran, ir iran

conclusions some il-10 promoter gene polymorphisms predisposed the infected hepatitis b virus cases to cirrhosis in our study population. patients and methods totally, 166 patients with chronic hepatitis b infection were enrolled. genotypes at different positions (i.e. -819, - 592, and - 1082) in the il-10 gene promoter were determined. results the c/a genotype at position -592, c/t genotype at...

Alireza Nakhaee, Kourosh Tirgar-Fakheri, Masoumeh Afzali, Mohammad Hashemi, Seyed Payman Tabatabaei,

Background: The protein of Niemann-pick type C1 (NPC1) gene promotes the egress of cholesterol from late endosomes and lysosomes to other cellular compartments and contributes to a process known as reverse cholesterol transport. This study aimed to examine whether promoter methylation of NPC1 is associated with risk of cardiovascular disease (CVD). Methods: Fifty CVD patients and 50 healthy sub...

Hypermethylation of CpG islands located in the promoter regions of genes is a major event in the development of the majority of cancer types, due to the subsequent aberrant silencing of important tumor suppressor genes. KLOTHO; a novel gene associated primarily with suppressing senescence has been shown to contribute to tumorigenesis as a result of its impaired function. Recently the relevance ...

Journal: :Cancer research 2005
Xin-xia Tian Deepak Rai Jun Li Chaozhong Zou Yujie Bai David Wazer Vimla Band Qingshen Gao

Germ line mutations in BRCA2 gene predispose women to early-onset familial breast and ovarian cancer. BRCA2 is a protein of multiple functions. In addition to its role in DNA double-strand break repair, BRCA2 also plays a role in stabilization of stalled DNA replication forks, cytokinesis, transcription regulation, mammalian gametogenesis, centrosome duplication, and suppression of cell prolife...

Journal: :Human molecular genetics 2012
Clare Turnbull Sheila Seal Anthony Renwick Margaret Warren-Perry Deborah Hughes Anna Elliott David Pernet Susan Peock Julian W Adlard Julian Barwell Jonathan Berg Angela F Brady Carole Brewer Glen Brice Cyril Chapman Jackie Cook Rosemarie Davidson Alan Donaldson Fiona Douglas Lynn Greenhalgh Alex Henderson Louise Izatt Ajith Kumar Fiona Lalloo Zosia Miedzybrodzka Patrick J Morrison Joan Paterson Mary Porteous Mark T Rogers Susan Shanley Lisa Walker Munaza Ahmed Diana Eccles D Gareth Evans Peter Donnelly Douglas F Easton Michael R Stratton Nazneen Rahman

There have been few definitive examples of gene-gene interactions in humans. Through mutational analyses in 7325 individuals, we report four interactions (defined as departures from a multiplicative model) between mutations in the breast cancer susceptibility genes ATM and CHEK2 with BRCA1 and BRCA2 (case-only interaction between ATM and BRCA1/BRCA2 combined, P = 5.9 × 10(-4); ATM and BRCA1, P=...

Journal: :Cell 2003
Luke Hughes-Davies David Huntsman Margarida Ruas Francois Fuks Jacqueline Bye Suet-Feung Chin Jonathon Milner Lindsay A Brown Forrest Hsu Blake Gilks Torsten Nielsen Michael Schulzer Stephen Chia Joseph Ragaz Anthony Cahn Lori Linger Hilal Ozdag Elena Cattaneo E. S Jordanova Edward Schuuring David S Yu Ashok Venkitaraman Bruce Ponder Aidan Doherty Samuel Aparicio David Bentley Charles Theillet Chris P Ponting Carlos Caldas Tony Kouzarides

The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DNA repair and transcriptional regulation. Here we identify a protein, EMSY, which binds BRCA2 within a region (exon 3) deleted in cancer. EMSY is capable of silencing the activation potential of BRCA2 exon 3, associates with chromatin regulators HP1beta and BS69, and localizes to sites of repair f...

Journal: :Cancer prevention research 2013
Asher Y Salmon Mali Salmon-Divon Tamar Zahavi Yulia Barash Rachel S Levy-Drummer Jasmine Jacob-Hirsch Tamar Peretz

Approximately 5% of all breast cancers can be attributed to an inherited mutation in one of two cancer susceptibility genes, BRCA1 and BRCA2. We searched for genes that have the potential to distinguish healthy BRCA1 and BRCA2 mutation carriers from noncarriers based on differences in expression profiling. Using expression microarrays, we compared gene expression of irradiated lymphocytes from ...

2012
Lawal AbdulRazzaq Oluwagbemiga Atoyebi Oluwole Adesunkanmi AbdulRasheed Kayode

With the discovery of the BRCA1 gene and other genetic mutations associated with breast cancer, it has been established that hereditary mutations account for up to 5% of patients presenting with breast cancer. We performed a systematic review of English Language Literature to determine the role of BRCA1 and BRCA2 gene mutations in African breast cancer patients. PUBMED and AJOL database were se...

Journal: :Cancer research 2008
Tomas Hucl Carlo Rago Eike Gallmeier Jonathan R Brody Myriam Gorospe Scott E Kern

The enormous scope of natural human genetic variation is now becoming defined. To accurately annotate these variants, and to identify those with clinical importance, is often difficult to assess through functional assays. We explored systematic annotation by using homologous recombination to modify a native gene in hemizygous (wt/Deltaexon) human cancer cells, generating a novel syngeneic varia...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید